LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 4 of 166
Next
>>
>
76 to 100 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	PD0325901	0.04	uM	LJP5	72	hr	1657	5590	5505	1.0154	1.0221
BT-20	PD0325901	0.04	uM	LJP6	72	hr	1657	4960	5505	0.9009	0.8582
BT-20	PD173074	0.04	uM	LJP6	72	hr	1657	6043	5505	1.0976	1.1396
BT-20	PD184352	0.04	uM	LJP5	72	hr	1657	5766	5505	1.0473	1.0677
BT-20	Pelitinib	0.04	uM	LJP5	72	hr	1657	5675	5505	1.0308	1.0441
BT-20	PF431396	0.04	uM	LJP5	72	hr	1657	4925	5505	0.8946	0.8492
BT-20	PF477736	0.04	uM	LJP5	72	hr	1657	5142	5505	0.9341	0.9057
BT-20	PF562271	0.04	uM	LJP6	72	hr	1657	5018	5505	0.9116	0.8734
BT-20	PHA-665752	0.04	uM	LJP5	72	hr	1657	5634	5505	1.0233	1.0334
BT-20	PHA-793887	0.04	uM	LJP6	72	hr	1657	3101	5505	0.5634	0.3753
BT-20	PI103	0.04	uM	LJP6	72	hr	1657	5425	5505	0.9854	0.9790
BT-20	PLX-4720	0.04	uM	LJP5	72	hr	1657	5745	5505	1.0435	1.0622
BT-20	QL-X-138	0.04	uM	LJP6	72	hr	1657	3961	5505	0.7196	0.5987
BT-20	QL-XII-47	0.04	uM	LJP6	72	hr	1657	4749	5505	0.8627	0.8035
BT-20	Radicicol	0.04	uM	LJP5	72	hr	1657	5049	5505	0.9171	0.8813
BT-20	Radicicol	0.04	uM	LJP6	72	hr	1657	4818	5505	0.8752	0.8215
BT-20	Seliciclib	0.04	uM	LJP5	72	hr	1657	5718	5505	1.0386	1.0553
BT-20	Ruxolitinib	0.04	uM	LJP5	72	hr	1657	5195	5505	0.9437	0.9194
BT-20	XL147	0.04	uM	LJP5	72	hr	1657	5818	5505	1.0569	1.0813
BT-20	Saracatinib	0.04	uM	LJP6	72	hr	1657	5648	5505	1.0259	1.0371
BT-20	Selumetinib	0.04	uM	LJP6	72	hr	1657	6126	5505	1.1127	1.1612
BT-20	Sirolimus	0.04	uM	LJP6	72	hr	1657	3525	5505	0.6404	0.4854
BT-20	Sorafenib	0.04	uM	LJP6	72	hr	1657	5122	5505	0.9304	0.9005
BT-20	SU11274	0.04	uM	LJP5	72	hr	1657	5686	5505	1.0328	1.0469
BT-20	Fedratinib	0.04	uM	LJP5	72	hr	1657	5683	5505	1.0323	1.0462

|<
<<
Previous
Page 4 of 166
Next
>>
>
76 to 100 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)